FDA to Review Chantix’ Psychiatric Side Effects

Kermit Cole
2
164

The Food & Drug Administration announced today it will convene a public meeting in October to review the psychiatric and behavioral side effects of Chantix. In 2009 the FDA required a “black box” label warning of hostility, agitation depression and suicidal thoughts after dozens of suicides and hundreds of reports of suicidal behavior were connected to the anti-smoking drug.

FDA Reviews Psychiatric Side Effects of Chantix (Boston.com)
FDA Reviews Psychiatric Side Effects of Chantix (ABC News)
FDA Reviewing Psychiatric Side Effects of Pfizer’s Chantix (Wall Street Journal)

Previous articleADHD Prescribing Differs Substantially in UK vs. US
Next articleWe Need to Go Back to Our Roots in the Civil Rights Movement
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]

2 COMMENTS

  1. My husband’s god son completed suicide while using Chantrix to quit smoking. He was only 26 years old and he left behind a wife and two children. He never had any history of a psychiatic diagnosis or treatment in his life. That medication and the people who marketed it are evil. As bad as smoking is, there are worse things than nicotine addiction: a broken clinical trial system, capitalist greed, and a haste to get potentially harmful medications to the market without long term safety studies.

  2. I did have a client who swore that the Chantix worked great for her. But, as someone who had the adverse withdrawal effects of the smoking cessation drug, Wellbutrin, misdiagnosed as “bipolar.” When my doctor tried to prescribe Chantix to me in 2010, I told him I’d research the drug and decide if it’d work well for me. The medical wall of silence toting moron told me not to research it, so I listened to the long list of ADRs on a commercial, and decided not to try it. It strikes me the medical community may believe it’s their right to turn all those utilizing the legal, but not medically controlled, “drugs” into their Guinea pigs for psychotropic experiments.

LEAVE A REPLY